On methods for radiometric surveying in radiotherapy bunkers
Authors:
E. Sergio Santini,
Renato Vasconcellos de Oliveira,
Nozimar do Couto,
Camila Salata,
Paulo Antônio Pereira Leal,
Flávia Cristina da Silva Teixeira,
Georgia Santos Joana
Abstract:
Radiometric surveys in radiotherapy bunkers have been carried out in Brazil for many years, both by the same radiotherapy facility for verification of shielding as by the regulatory agency for licensing and control purposes. In recent years, the Intensity Modulated Radiation Therapy (IMRT) technique has been gradually incorporated into many facilities. Therefore, it has been necessary to consider…
▽ More
Radiometric surveys in radiotherapy bunkers have been carried out in Brazil for many years, both by the same radiotherapy facility for verification of shielding as by the regulatory agency for licensing and control purposes. In recent years, the Intensity Modulated Radiation Therapy (IMRT) technique has been gradually incorporated into many facilities. Therefore, it has been necessary to consider the increased leakage component that has an important impact on the secondary walls. For that, a radiometric survey method has been used that considers an increased "time of beam - on" for the secondary walls. In this work we discuss two methods of doing this: the first considers that this "time of beam - on" affects the sum of the two components, leakage and scattered. In another method it is considered that only the leakage component is affected by this extended "time of beam - on ". We compare the methods and show that for secondary walls with $U=1$ the first method overestimates dose rates by important percentages and for secondary walls with $U<1$ it can both overestimate or underestimate the dose rates, depending on the parameters of the project. An optimized procedure is proposed, according to the use factor ($U$) of the secondary wall to be measured.
△ Less
Submitted 6 December, 2023; v1 submitted 28 December, 2021;
originally announced December 2021.
Computationally driven discovery of SARS-CoV-2 Mpro inhibitors: from design to experimental validation
Authors:
L. El Khoury,
Z. **g,
A. Cuzzolin,
A. Deplano,
D. Loco,
B. Sattarov,
F. Hédin,
S. Wendeborn,
C. Ho,
D. El Ahdab,
T. Jaffrelot Inizan,
M. Sturlese,
A. Sosic,
M. Volpiana,
A. Lugato,
M. Barone,
B. Gatto,
M. Ludovica Macchia,
M. Bellanda,
R. Battistutta,
C. Salata,
I. Kondratov,
R. Iminov,
A. Khairulin,
Y. Mykhalonok
, et al. (10 additional authors not shown)
Abstract:
We report a fast-track computationally-driven discovery of new SARS-CoV2 Main Protease (M$^{pro}$) inhibitors whose potency range from mM for initial non-covalent ligands to sub-$μ$M for the final covalent compound (IC50=830 +/- 50 nM). The project extensively relied on high-resolution all-atom molecular dynamics simulations and absolute binding free energy calculations performed using the polariz…
▽ More
We report a fast-track computationally-driven discovery of new SARS-CoV2 Main Protease (M$^{pro}$) inhibitors whose potency range from mM for initial non-covalent ligands to sub-$μ$M for the final covalent compound (IC50=830 +/- 50 nM). The project extensively relied on high-resolution all-atom molecular dynamics simulations and absolute binding free energy calculations performed using the polarizable AMOEBA force field. The study is complemented by extensive adaptive sampling simulations that are used to rationalize the different ligands binding poses through the explicit reconstruction of the ligand-protein conformation spaces. Machine Learning predictions are also performed to predict selected compound properties. While simulations extensively use High Performance Computing to strongly reduce time-to-solution, they were systematically coupled to Nuclear Magnetic Resonance experiments to drive synthesis and to in vitro characterization of compounds. Such study highlights the power of in silico strategies that rely on structure-based approaches for drug design and allows to address the protein conformational multiplicity problem. The proposed fluorinated tetrahydroquinolines open routes for further optimization of M$^{pro}$ inhibitors towards low nM affinities.
△ Less
Submitted 24 January, 2022; v1 submitted 11 October, 2021;
originally announced October 2021.
